Brief: Salarius Pharmaceuticals Announces 1-For-25 Reverse Stock Split

Decoy Therapeutics

14/10/2022 14:05

Oct 14 (Reuters) - Salarius Pharmaceuticals Inc
 SLRX.O :
    * SALARIUS PHARMACEUTICALS ANNOUNCES 1-FOR-25 REVERSE STOCK
SPLIT
    * SALARIUS PHARMACEUTICALS INC - REVERSE STOCK SPLIT
INTENDED TO
ENABLE SALARIUS TO REGAIN COMPLIANCE WITH $1.00 MINIMUM CLOSING
BID PRICE REQUIRED
    * SALARIUS PHARMACEUTICALS INC - BEGINNING OCTOBER 17, 2022,
SALARIUS' COMMON STOCK WILL TRADE ON NASDAQ CAPITAL MARKET ON A
SPLIT-ADJUSTED BASIS
    * SALARIUS PHARMACEUTICALS INC - CO'S COMMON STOCK WILL
TRADE ON
NASDAQ CAPITAL MARKET ON A SPLIT-ADJUSTED BASIS UNDER A NEW
CUSIP NUMBER 79400X305

Source text for Eikon:  ID:nGNX8lWqpB 
Further company coverage:  SLRX.O 
 ((Reuters.Briefs@thomsonreuters.com;))